KN046 in Patients With Advanced Non-small Cell Lung Cancer
Clinical trial NCT03838848 · TERMINATED
Trial details
- NCT number
- NCT03838848
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-05
- Primary completion
- 2022-07-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.